Uta Naumann

910 total citations
32 papers, 680 citations indexed

About

Uta Naumann is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Uta Naumann has authored 32 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 21 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Uta Naumann's work include Hepatitis C virus research (20 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). Uta Naumann is often cited by papers focused on Hepatitis C virus research (20 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). Uta Naumann collaborates with scholars based in Germany, United Kingdom and Spain. Uta Naumann's co-authors include Thomas Berg, U. Hopf, P. Neuhaus, Ulrike Protzer, Karl-Hermann Meyer zum Büschenfelde, G Gerken, Ralf Bartenschlager, Wolf O. Bechstein, Stefan Zeuzem and G Teuber and has published in prestigious journals such as Gastroenterology, PLoS ONE and Development.

In The Last Decade

Uta Naumann

30 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uta Naumann Germany 12 578 575 70 37 36 32 680
Giovanna Fattovich Italy 6 498 0.9× 562 1.0× 100 1.4× 21 0.6× 67 1.9× 7 670
E. Chiaberge Italy 8 857 1.5× 848 1.5× 97 1.4× 33 0.9× 19 0.5× 22 922
Omar Galdame Argentina 14 332 0.6× 336 0.6× 32 0.5× 53 1.4× 37 1.0× 39 450
Barbara Langer Germany 9 461 0.8× 457 0.8× 36 0.5× 22 0.6× 42 1.2× 17 572
Antonio Madejón Spain 18 492 0.9× 524 0.9× 167 2.4× 31 0.8× 69 1.9× 35 678
Dessislava I. Dimitrova United States 8 588 1.0× 688 1.2× 161 2.3× 16 0.4× 67 1.9× 11 775
K Ohba Japan 4 397 0.7× 420 0.7× 55 0.8× 24 0.6× 21 0.6× 6 474
Santa Brancatelli Italy 14 382 0.7× 370 0.6× 49 0.7× 22 0.6× 27 0.8× 22 477
Hoofnagle Jh United States 10 522 0.9× 505 0.9× 49 0.7× 77 2.1× 21 0.6× 20 603
N.V. Naoumov United Kingdom 10 615 1.1× 702 1.2× 48 0.7× 80 2.2× 31 0.9× 18 755

Countries citing papers authored by Uta Naumann

Since Specialization
Citations

This map shows the geographic impact of Uta Naumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uta Naumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uta Naumann more than expected).

Fields of papers citing papers by Uta Naumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uta Naumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uta Naumann. The network helps show where Uta Naumann may publish in the future.

Co-authorship network of co-authors of Uta Naumann

This figure shows the co-authorship network connecting the top 25 collaborators of Uta Naumann. A scholar is included among the top collaborators of Uta Naumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uta Naumann. Uta Naumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marques, Inês J., Alexander Ernst, Andrés Sanz-Morejón, et al.. (2022). Wt1 transcription factor impairs cardiomyocyte specification and drives a phenotypic switch from myocardium to epicardium. Development. 149(6). 11 indexed citations
2.
Marques, Inês J., Andrés Sanz-Morejón, Uta Naumann, et al.. (2022). WT1 transcription factor impairs cardiomyocyte specification and drives a phenotypic switch from myocardium to epicardium. Zenodo (CERN European Organization for Nuclear Research). 2 indexed citations
3.
Stoehr, Albrecht, Hartwig Klinker, G Teuber, et al.. (2020). Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease - Data from the German Hepatitis C-Registry (DHC-R). Zeitschrift für Gastroenterologie. 2 indexed citations
4.
Naumann, Uta, et al.. (2018). Kidney regeneration in fish. The International Journal of Developmental Biology. 62(6-7-8). 419–429. 8 indexed citations
5.
Perner, Birgit, et al.. (2016). Function and Regulation of the Wilms’ Tumor Suppressor 1 (WT1) Gene in Fish. Methods in molecular biology. 1467. 119–128. 1 indexed citations
6.
Naumann, Uta, et al.. (2016). Fluorescence-Activated Cell Sorting (FACS) Protocol for Podocyte Isolation in Adult Zebrafish. Methods in molecular biology. 1467. 133–136. 3 indexed citations
7.
Suomi, Fumi, Katja E. Menger, Geoffray Monteuuis, et al.. (2014). Expression and Evolution of the Non-Canonically Translated Yeast Mitochondrial Acetyl-CoA Carboxylase Hfa1p. PLoS ONE. 9(12). e114738–e114738. 13 indexed citations
8.
Berg, Thomas, E. Schreier, Uta Naumann, et al.. (2008). Hepatitis-G-Virus-Infektion: epidemiologische Aspekte und klinische Relevanz. DMW - Deutsche Medizinische Wochenschrift. 122(9). 268–274. 2 indexed citations
9.
Cornberg, Markus, Holger Hinrichsen, G Teuber, et al.. (2002). Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C. Journal of Hepatology. 37(6). 843–847. 25 indexed citations
10.
Seehofer, Daniel, Nada Rayes, Uta Naumann, et al.. (2001). PREOPERATIVE ANTIVIRAL TREATMENT AND POSTOPERATIVE PROPHYLAXIS IN HBV-DNA POSITIVE PATIENTS UNDERGOING LIVER TRANSPLANTATION. Transplantation. 72(8). 1381–1385. 53 indexed citations
11.
Rayes, Nada, Daniel Seehofer, U. Hopf, et al.. (2001). COMPARISON OF FAMCICLOVIR AND LAMIVUDINE IN THE LONG-TERM TREATMENT OF HEPATITIS B INFECTION AFTER LIVER TRANSPLANTATION. Transplantation. 71(1). 96–101. 26 indexed citations
12.
Zeuzem, Stefan, G Teuber, Uta Naumann, et al.. (2000). Randomized, double-blind, placebo-controlled trial of interferon Alfa2a with and without amantadine as initial treatment for chronic hepatitis C. Hepatology. 32(4). 835–841. 65 indexed citations
13.
Berg, Thomas, et al.. (2000). Einfluss von Ribavirin auf die Dynamik der Hepatitis-C-Virämie bei Interferon-α-behandelten Patienten mit Response oder Nonresponse. Zeitschrift für Gastroenterologie. 38(11). 881–886. 11 indexed citations
14.
Rayes, Nada, R. Neuhaus, Uta Naumann, et al.. (1999). Treatment of hepatitis B-reinfection or de novo-infection after liver transplantation with famciclovir—how effective is it?. Transplantation Proceedings. 31(1-2). 481–482. 6 indexed citations
15.
Protzer, Ulrike, Uta Naumann, Ralf Bartenschlager, et al.. (1998). Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology. 27(1). 254–263. 230 indexed citations
16.
Rayes, Nada, Wolf O. Bechstein, Stefan G. Tullius, et al.. (1998). Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy. Transplantation Proceedings. 30(5). 1846–1847. 1 indexed citations
18.
Rayes, Nada, Wolf O. Bechstein, Hans‐Dieter Volk, et al.. (1997). Distribution of lymphocyte subtypes in liver transplant recipients. Transplantation Proceedings. 29(1-2). 501–502. 5 indexed citations
19.
Berg, Thomas, et al.. (1996). Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. Journal of Hepatology. 25(5). 763–768. 53 indexed citations
20.
Berg, Thomas, Uta Naumann, Takumi Fukumoto, et al.. (1996). GB VIRUS C INFECTION IN PATIENTS WITH CHRONIC HEPATITIS B AND C BEFORE AND AFTER LIVER TRANSPLANTATION. Transplantation. 62(6). 711–714. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026